Appels à projets H2020 "Innovative Medicines Initiative 2 - Calls 22 & 23"

DL 29/09/2020 - 17:00 Brussels time - Closing date of calls H2020 IMI2 22 & 23

The Innovative Medicines Initiative (IMI) is launching the last Calls for proposals under the IMI2 programme, with topics on tackling cancer through artificial intelligence, antimicrobial resistance, neurodegenerative diseases, rare disease diagnosis, and more.

IMI2 - Call 22

IMI2 - Call 23

  • Call ID: H2020-JTI-IMI2-2020-23-two-stage
  • Action Type: RIA – Research and Innovation Actions
  • Topics on tackling cancer through artificial intelligence, antimicrobial resistance, neurodegenerative diseases, rare disease diagnosis, the return of clinical trial data to participants, and patient adherence
  • More details

Topics

Dealines

  • Stage 1 submission deadline: 29 September 2020 (17:00 Brussels time)
  • Stage 2 submission deadline: 17 March 2021 (17:00 Brussels time)

IMI2 – Call 22 & 23 webinars & recordings

Contact UCLouvain
Please, feel free to contact Ms Mahdia Abdelouahab (ADRE/RINT - Phone: +32 (0)10 47.24.80) if you need further information or plan to participate.

Publié le 29 juin 2020